The Team
The founding partners of Baigo Capital have worked together for many years having completed more than 50 mid market healthcare transactions. Their backgrounds are in private equity, the healthcare industry and investment banking.
The founding partners are:
Marcus graduated from the London School of Economics with a Master of Science degree and worked for the OECD as an economist. He qualified as a chartered accountant and Wirtschaftsprüfer with Price Waterhouse, transferred to their corporate finance practice and became a partner. After 12 years with Price Waterhouse he joined Arthur Andersen as a partner to run their European Healthcare Group and subsequently founded the Healthcare Investment Banking Group at Sal. Oppenheim where he served as a Managing Director and Head of Healthcare Investment Banking for 6 years. Marcus has worked in the healthcare industry for over 10 years and has completed more than 40 healthcare transactions.
Marcus is responsible for deal origination and for investor relations.
Frank graduated from the University of Karlsruhe with a Masters Degree in Business and Engineering (Diplom Wirtschaftsingenieur). He worked for major international accounting firms Price Waterhouse and Arthur Andersen for 8 years initially in the accounting division and then in their corporate finance groups focusing on Mergers and Acquisitions in the healthcare industry. He spent 6 years at Sal. Oppenheim where he was a Managing Director and Head of the Healthcare M&A Group. He has advised on more than 20 completed healthcare transactions.
Frank is responsible for deal execution and is the CFO of Baigo Capital.
Dariusch graduated from the University of Freiburg with a PhD in Chemistry and conducted postdoctoral studies at UC Berkeley. He began his professional career in R&D at Degussa AG following which he took an MBA at IESE in Barcelona. He then joined Schering AG where he held positions in strategic marketing and operations. He was posted to the US to launch Betaferon and subsequently returned to Europe, to launch the product there. For the last 12 years Dariusch worked as a Pharma-CEO at Schering in Eastern Europe, then at Madaus SA in Spain. In 2003 he founded the pharmaceutical business Lab. Gebro Pharma SA which he built to a € 25 m turnover and successfully divested in 2007.
Dariusch has over 20 years experience in the healthcare sector and an extensive international industry network.
Dariusch is responsible for deal origination and portfolio management.
Markus graduated with an MBA from the European Business School and has spent most of his career in the private equity industry. He started his career with Deutsche Beteiligungs AG, worked for Advent International and 3i PLC. He has also served as CFO and then CEO of the private equity backed company ACG which he led to an IPO on the German stockmarket. He has also gained experience as a co-founder of FBH a private equity firm focused on turnarounds.
Markus is responsible for deal execution and for portfolio management.